Eyepoint Pharmaceuticals Inc (EYPT) — Defensive Interval Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Defensive Interval Ratio of 1583 days as of September 2025. Defensive assets of $130.49 Million (cash $-, short-term investments $129.44 Million, receivables $1.04 Million) cover 1583 days of daily cash needs of $82.45K/day. Check tangible equity quality of Eyepoint Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Eyepoint Pharmaceuticals Inc Defensive Interval Ratio (2000–2024)
This chart shows how Eyepoint Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 24 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 1583 days, meaning defensive assets of $130.49 Million can fund 1583 days of operations without new revenue. Also explore Eyepoint Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Eyepoint Pharmaceuticals Inc (2000–2024)
The table below presents the year-by-year Defensive Interval Ratio for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Eyepoint Pharmaceuticals Inc worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2023 days | $271.82 Million | $134.38K/day | $- | $271.21 Million | ▲ +1731 days |
| 2023 | 292 days | $50.59 Million | $173.32K/day | $- | $49.79 Million | ▼ -389 days |
| 2022 | 681 days | $64.43 Million | $94.62K/day | $- | $48.93 Million | ▼ -111 days |
| 2021 | 792 days | $51.32 Million | $64.82K/day | $- | $32.97 Million | ▲ +560 days |
| 2020 | 232 days | $9.45 Million | $40.79K/day | $- | $0.00 | ▼ -128 days |
| 2019 | 360 days | $11.37 Million | $31.56K/day | $- | $- | ▲ +354 days |
| 2018 | 6 days | $353.00K | $59.35K/day | $- | $- | ▼ -11 days |
| 2017 | 17 days | $251.00K | $14.49K/day | $- | $0.00 | ▼ -981 days |
| 2016 | 998 days | $13.93 Million | $13.95K/day | $- | $13.68 Million | ▼ -81 days |
| 2015 | 1080 days | $9.90 Million | $9.17K/day | $- | $9.41 Million | ▲ +467 days |
| 2014 | 612 days | $3.57 Million | $5.82K/day | $- | $2.94 Million | ▲ +182 days |
| 2013 | 430 days | $3.89 Million | $9.05K/day | $- | $3.37 Million | ▼ -781 days |
| 2012 | 1211 days | $10.54 Million | $8.71K/day | $- | $9.95 Million | ▲ +327 days |
| 2011 | 884 days | $12.18 Million | $13.79K/day | $- | $11.22 Million | ▲ +524 days |
| 2010 | 360 days | $2.89 Million | $8.04K/day | $- | $2.05 Million | ▲ +228 days |
| 2009 | 132 days | $3.16 Million | $23.89K/day | $- | $2.05 Million | ▲ +108 days |
| 2008 | 25 days | $885.00K | $35.91K/day | $- | $- | ▼ -5 days |
| 2007 | 30 days | $1.47 Million | $49.55K/day | $- | $- | ▲ +5 days |
| 2006 | 25 days | $1.62 Million | $65.45K/day | $- | $- | ▼ -102 days |
| 2005 | 126 days | $538.73K | $4.26K/day | $- | $- | ▲ +0 days |
| 2004 | 126 days | $538.73K | $4.26K/day | $- | $- | ▲ +62 days |
| 2003 | 64 days | $236.60K | $3.69K/day | $- | $- | ▲ +21 days |
| 2002 | 43 days | $68.79K | $1.61K/day | $- | $- | ▼ -163 days |
| 2000 | 206 days | $82.06K | $399.29/day | $- | $- | — |